Skip to main content

Medication Safety

Featured Article
Apotex Corp is voluntarily recalling 55,620 bottles of guanfacine extended-release tablets, 2 mg, because trace amounts of the schizophrenia drug quetiapine fumarate were found in products from one…
Alembic Pharmaceuticals Limited is recalling more than 12,000 bottles of telmisartan tablets after a bottle labelled to contain 20-mg tablets was found to contain 40-mg tablets.


Damon Birkemeier, PharmD, FDA/ISMP safe medication management fellow, provides recommended sterile compounding best practices identified by ISMP.
Damon Birkemeier, PharmD, FDA/ISMP safe medication management fellow, discusses survey results concerning compounding technologies and common safety errors, as well as some of the biggest perceived challenges.
Michael Cawley, PharmD, discusses the recent news from the FDA on benzodiazepines, which includes new boxed warnings for the use of these medications, and changes to the prescribing information and patient medication guides.
A Class II recall is active for a prescription analgesic injection used during anesthetic periods, premedication, induction and maintenance, and in the immediate postoperative period.
Back to Top